ARCHIVES

In Brief: white House Names Phillip Sharp To NCAB; Shine Re-appointed As IOM President

This article is from The Cancer Letter archive.

Vol. 22 No. 37 | September 27, 1996

Download PDF Visit The Full Archive

Related Articles

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

January 12, 1979

DCT Advisors OK Recompetition Of Drug Contacts

March 15, 1991

Study Of Tamoxifen And Raloxifene Enrolls 6,000 In First Year; 5 Percent Are Minorities

July 28, 2000

Oncologist Urge FDA to Allow Cancer Patients Access to Silicone Implants, But Continue Study

March 6, 1992

Bevacizumab And Irinotecan May Increase Survival Of GBM

October 26, 2007